Edward John Allera recently made a presentation in Southern California about practical strategies to implement wireless technology/device use in the health care system. Officially titled, "Practical Approaches to Wireless Health Innovation: Diagnostics, Delivery & Cost," the program covered the many questions facing the developing wireless health care industry, including the viability of wireless health devices, the ability of private-sector health care companies to develop sound business models that support wireless health delivery and the adaptation of federal reimbursement strategies to fit the fledging market.
Edward Allera focuses his practice on the development of new products and business opportunities in the areas of pharmaceuticals and technology, especially regarding the regulation and promotion of drugs, biologics and devices. Allera is a managing shareholder of the Washington, D.C., office of Buchanan Ingersoll & Rooney PC, as well as chairman of the firm's FDA/Biotechnology Section.
He began his career at the Food and Drug Administration (FDA), where he served as associate chief counsel. The breadth of his practice allows him to keep a finger on the pulse of the most recent trends in FDA regulatory activity. As a managing partner in D.C., Allera has been able to build a rare, coordinated team that integrates the firm's Food and Drug, Health Care and Centers for Medicare and Medicaid Services (CMS) expertise with Federal Government Affairs expertise into a seamless unit. Allera, along with the FDA team, has worked with companies dealing with the Office of the Inspector General of the Department of Health and Human Services, the Department of Justice, Congress, and numerous state officials on a variety of issues.